Saluda Medical is a pioneering brand that is dedicated to transforming the lives of patients suffering from chronic neurological conditions. With a mission to revolutionize neuromodulation, Saluda offers disruptive solutions that provide effective and innovative treatment options. Founded in 2013, Saluda Medical has built a strong reputation based on more than a decade of research and development, as well as clinical experience.

One of their groundbreaking innovations is the use of Evoked Compound Action Potentials (ECAPs), which directly measure the spinal cord's physiological response to stimulation. This smart neuromodulation therapy allows for personalized treatment and improved patient outcomes. Saluda Medical is committed to challenging the conventional through disruptive technologies, investing in clinical evidence, and conducting research into neurological diseases and disorders with the greatest unmet needs.

With a dedicated team and a strong focus on quality and patient-centric care, Saluda Medical is revolutionizing the field of neuromodulation and providing hope to patients worldwide